By RYOSUKE NONAKA/ Staff Writer
May 19, 2019 at 18:10 JST
Tasuku Honjo, a 2018 co-winner of the Nobel Prize in Physiology or Medicine (Asahi Shimbun file photo)
Kyoto University will grant the desire of its most recent Nobel laureate, immunologist Tasuku Honjo, establishing Japan’s first research center on cancer immunotherapy.
The “center for general research on cancer immunity” will be headed by Honjo, 77, who was the co-winner of the Nobel Prize in Physiology or Medicine in 2018.
Researchers there will comprehensively study cancer immunotherapy from the basics to applications to boost the body's defenses to fight the disease.
According to the university, the research center will consist of five or six divisions that will work to clarify the basic mechanism of immunity, develop medicines for cancer treatment and conduct clinical trials with the drugs.
The state-run university plans to ask the education ministry to earmark a budget for the establishment of the center in April 2020.
Honjo, who won the Nobel Prize for his study that had led to the development of cancer treatment medicine Opdivo, has called for creation of such a research center and support for young researchers. He is a distinguished professor of molecular immunology at Kyoto University.
Visit this page for the latest news on Japan’s battle with the novel coronavirus pandemic.
Cooking experts, chefs and others involved in the field of food introduce their special recipes intertwined with their paths in life.
Here is a collection of first-hand accounts by “hibakusha” atomic bomb survivors.
The Asahi Shimbun aims “to achieve gender equality and empower all women and girls” through its Gender Equality Declaration.
Let’s explore the Japanese capital from the viewpoint of wheelchair users and people with disabilities with Barry Joshua Grisdale.
